VOYA Investment Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Buy
321,512
+7,072
+2% +$209K 0.01% 600
2026
Q1
$8.71M Buy
314,440
+52,503
+20% +$1.35M 0.01% 666
2025
Q4
$5.68M Sell
261,937
-235,886
-47% -$4.65M 0.01% 819
2025
Q3
$7.53M Buy
497,823
+455,497
+1,076% +$5.64M 0.01% 740
2025
Q2
$477K Sell
42,326
-9,980
-19% -$108K ﹤0.01% 1923
2025
Q1
$528K Buy
52,306
+638
+1% +$6.9K ﹤0.01% 1850
2024
Q4
$611K Sell
51,668
-3,634
-7% -$43K ﹤0.01% 1858
2024
Q3
$638K Sell
55,302
-96,666
-64% -$1.1M ﹤0.01% 1869
2024
Q2
$1.61M Sell
151,968
-286,187
-65% -$3.14M ﹤0.01% 1386
2024
Q1
$4.62M Sell
438,155
-54,757
-11% -$590K ﹤0.01% 1040
2023
Q4
$5.54M Sell
492,912
-509
-0.1% -$4.96K 0.01% 969
2023
Q3
$5.76M Buy
493,421
+239,093
+94% +$2.7M 0.01% 913
2023
Q2
$2.56M Buy
254,328
+108,938
+75% +$974K ﹤0.01% 1249
2023
Q1
$1.07M Buy
+145,390
New +$1.2M ﹤0.01% 1616

Other funds holding ROIV

VOYA Investment Management's ROIV Position: Q2 2026 in Review

VOYA Investment Management increased its Roivant Sciences (ROIV) stake by 2.2% in Q2 2026, buying an estimated $209K and bringing the position to 321,512 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #600.

VOYA Investment Management first reported a position in ROIV in Q1 2023 and has held it in 14 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • VOYA Investment Management held 321,512 shares of Roivant Sciences worth $11.4M as of Q2 2026.
  • VOYA Investment Management bought 7,072 Roivant Sciences shares in Q2 2026, an estimated $209K.
  • Roivant Sciences made up 0.01% of VOYA Investment Management's portfolio in Q2 2026, its #600 holding.
  • VOYA Investment Management first reported a position in Roivant Sciences in Q1 2023 and has held it in 14 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.